chartexchange

BioCryst to Report Third Quarter 2026 Financial Results on November 4

GlobeNewswire Inc. | Oct 21, 2026 4:01 PM EDT

RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial results on Wednesday, November 4, 2026.

Read original article